PubRank

Uma Yasothan

Author PubWeight™ 38.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pegloticase. Nat Rev Drug Discov 2011 1.76
2 Vemurafenib. Nat Rev Drug Discov 2011 1.68
3 Tetrabenazine. Nat Rev Drug Discov 2009 1.60
4 Dabigatran etexilate. Nat Rev Drug Discov 2008 1.41
5 Sipuleucel-T. Nat Rev Drug Discov 2010 1.37
6 Tocilizumab. Nat Rev Drug Discov 2009 1.36
7 Denosumab. Nat Rev Drug Discov 2010 1.31
8 Everolimus. Nat Rev Drug Discov 2009 1.29
9 Asenapine. Nat Rev Drug Discov 2009 1.21
10 Tolvaptan. Nat Rev Drug Discov 2009 1.13
11 Febuxostat. Nat Rev Drug Discov 2009 1.12
12 Ivacaftor. Nat Rev Drug Discov 2012 1.12
13 Golimumab. Nat Rev Drug Discov 2009 1.11
14 Lacosamide. Nat Rev Drug Discov 2008 1.09
15 Crizotinib. Nat Rev Drug Discov 2011 1.05
16 Plerixafor. Nat Rev Drug Discov 2009 1.04
17 Brentuximab vedotin. Nat Rev Drug Discov 2012 1.04
18 Pazopanib. Nat Rev Drug Discov 2010 1.02
19 Ustekinumab. Nat Rev Drug Discov 2009 1.02
20 Certolizumab pegol. Nat Rev Drug Discov 2008 0.98
21 Ruxolitinib. Nat Rev Drug Discov 2012 0.96
22 Telavancin. Nat Rev Drug Discov 2009 0.94
23 Ecallantide. Nat Rev Drug Discov 2010 0.91
24 Prasugrel. Nat Rev Drug Discov 2009 0.90
25 Alvimopan. Nat Rev Drug Discov 2008 0.86
26 Romiplostim. Nat Rev Drug Discov 2008 0.86
27 Velaglucerase alfa. Nat Rev Drug Discov 2010 0.85
28 Roflumilast. Nat Rev Drug Discov 2010 0.85
29 Belimumab. Nat Rev Drug Discov 2011 0.83
30 Pirfenidone. Nat Rev Drug Discov 2011 0.83
31 Pasireotide. Nat Rev Drug Discov 2012 0.81
32 Inhaled aztreonam. Nat Rev Drug Discov 2010 0.81
33 Osteoporosis: overview and pipeline. Nat Rev Drug Discov 2008 0.81
34 Ofatumumab. Nat Rev Drug Discov 2010 0.81
35 Rheumatoid arthritis market. Nat Rev Drug Discov 2009 0.79
36 Bendamustine. Nat Rev Drug Discov 2008 0.79